首都医科大学学报 ›› 2025, Vol. 46 ›› Issue (5): 812-819.doi: 10.3969/j.issn.1006-7795.2025.05.008

• 麻醉与神经科学 • 上一篇    下一篇

地氟烷对鼻内镜下垂体腺瘤切除术患者麻醉恢复质量的影响:一项随机对照研究

付宇翾1,周扬1,崔译丹2,吴侑煊1,于芸1,韩如泉1*   

  1. 1.首都医科大学附属北京天坛医院麻醉科,北京 100070;2.中国核工业北京四○一医院麻醉科,北京 100006
  • 收稿日期:2025-07-01 修回日期:2025-08-11 出版日期:2025-10-21 发布日期:2025-10-22
  • 通讯作者: 韩如泉 E-mail:ruquan.han@ccmu.edu.cn
  • 基金资助:
    北京市医管局扬帆计划项目(ZYLX201708),北京市医管局登峰计划人才团队项目(DFL20180502),首都医科大学附属北京天坛医院院青年基金项目(QNLC-2025-08)。

Effects of desflurane on the quality of the anesthesia emergence period in patients undergoing transnasal pituitary adenoma resection: a randomized controlled study

Fu Yuxuan1, Zhou Yang1, Cui Yidan2, Wu Youxuan1, Yu Yun1, Han Ruquan1*   

  1. 1.Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China;2. Department of Anesthesiology, Beijing Nuclear Industry Hospital, Beijing 100006, China
  • Received:2025-07-01 Revised:2025-08-11 Online:2025-10-21 Published:2025-10-22
  • Supported by:
    This study was supported by Beijing Municipal Administration of Hospitals' Sail Plan (ZYLX201708),Beijing Municipal Administration of Hospitals' Summit Plan Talent Team (DFL20180502),Youth Fund of Beijing Tiantan Hospital, Capital Medical University(QNLC-2025-08)

摘要: 目的  比较地氟烷吸入麻醉与丙泊酚全凭静脉麻醉对经鼻内镜垂体腺瘤切除术患者术后恢复质量的影响,为优化该类手术的麻醉方案提供循证依据。方法  采用单中心、前瞻性、随机对照研究设计,纳入112例拟行经鼻内镜垂体腺瘤切除术的患者,采用数字表法随机分为地氟烷组(n=56)和丙泊酚组(n=56)。地氟烷组采用地氟烷[0.7~1.0 肺泡最低有效浓度(minimum alveolar concentration,MAC]联合瑞芬太尼维持麻醉,丙泊酚组采用丙泊酚(4~6 mg·kg-1·h-1)联合瑞芬太尼维持麻醉。主要结局指标为麻醉药物停用后至Aldrete评分达9分的时间,次要指标包括苏醒时间、拔管时间以及术后住院时间。结果  地氟烷组Aldrete评分达9分的时间显著短于丙泊酚组(13.0 min vs 16.5 min,P=0.003),意识恢复时间(14.0 min vs 16.5 min,P=0.009)和拔管时间(13.0 min vs 16.5 min,P=0.003)亦明显缩短。然而,地氟烷组术后躁动(17.9% vs 3.6%,P=0.015)和呕吐发生率(19.6% vs 5.4%,P=0.022)较高,两组严重躁动发生率差异无统计学意义。术后24 h恢复质量[恢复质量15项量表(Quality of Recovery-15, QoR-15)]评分和住院时间组间差异无统计学意义。结论  地氟烷麻醉可显著加速经鼻内镜垂体腺瘤切除术患者的术后恢复,但可能增加轻度躁动和呕吐风险。临床应用中需权衡不良反应,采取针对性预防措施。

关键词: 围术期管理, 地氟烷, 丙泊酚, 垂体腺瘤, 神经外科, 围术期恢复质量

Abstract: Objective  To compare the effects of desflurane inhalation anesthesia versus propofol total intravenous anesthesia on postoperative recovery quality in patients undergoing endoscopic transnasal pituitary adenoma resection, and to provide evidence-based recommendations for optimizing anesthetic management in this surgical population. Methods  This single-center, prospective, randomized controlled trial enrolled 112 patients scheduled for endoscopic transnasal pituitary adenoma resection, who were randomly assigned to either the desflurane group (n=56) or the propofol group (n=56). The desflurane group received desflurane [0.7-1.0 minimum alveolar concentration(MAC)] combined with remifentanil for anesthesia maintenance, whereas the propofol group received propofol (4-6 mg·kg-1·h-1) with remifentanil. The primary outcome was defined as the time from discontinuation of anesthetics to achieving an Aldrete score of 9. Secondary outcomes included emergence time, extubation time, and incidences of postoperative agitation and vomiting. Results  Patients receiving desflurane achieved an Aldrete score of 9 significantly faster than those in the propofol group (13.0 min vs 16.5 min, P=0.003). Similarly, both emergence time (14.0 min vs 16.5 min, P=0.009) and extubation time (13.0 min vs 16.5 min, P=0.003) were significantly shorter in the desflurane group. However, the desflurane group had higher incidences of postoperative agitation (17.9% vs 3.6%, P=0.015) and vomiting (19.6% vs 5.4%, P=0.022). No significant difference was observed in severe agitation rates or 24 h postoperative recovery quality [Quality of Recovery-15(QoR-15) scores] between groups. Conclusion  Desflurane anesthesia significantly accelerates postoperative recovery in patients undergoing endoscopic transnasal pituitary adenoma resection, however, it may increase risks of mild agitation and vomiting. In clinical applications, it is necessary to balance recovery benefits against potential adverse effects, and take targeted prophylactic measures.

Key words: perioperative management, desflurane, propofol, pituitary adenoma, neurosurgery, quality of perioperative recovery

中图分类号: